Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Letrozole alters transcriptomic profiles in infrapatellar fat pad from female mice: Possible involvement of aromatase inhibitor-induced arthralgias

ABSTRACT: Letrozole, is an aromatase inhibitors (AIs) preventing estrogen synthesis from testosterone, and it induces many side effects, known as the aromatase inhibitor-associated musculoskeletal syndrome (AIMSS), including arthralgias. The infrapatellar fat pad (IFP), rectus femoris and tendon are critical structural and functional components of the knee musculoskeletal system. The IFP is metabolically active and acts as a key regulator of joint inflammation and homeostasis. Meanwhile, rectus femoris and tendon tissues are highly susceptible to estrogen fluctuation and inflammatory insult, making them pivotal peripheral targets closely linked to the onset and progression of AIMSS. However, how letrozole intervention induces pathological and molecular alterations in these three key tissues remains unclear. Given the above research gaps,We integrated transcriptomic profiling to characterize molecular signatures underlying letrozole-related musculoskeletal injury. This work aims to uncover the potential aetiological mechanisms of AIMSS and identify novel molecular biomarkers and therapeutic targets for the early prevention and clinical intervention of AIMSS.

ORGANISM(S): Mus musculus

PROVIDER: GSE330805 | GEO | 2026/06/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Synovium and Infrapatellar fat pad are one functional tissue unit sharing common mesenchymal progenitors and undergoing coordinated changes in osteoarthritis

Project description:The Infrapatellar fat pads (IFP) are two wedge shaped fatty structures situated below the kneecap (patella), lying either side of the patellar tendon, first described by Hoffa in 1904. Recent studies reveal that knee OA causes pathological fibrosis, stiffening, and inflammation of the synovium and IFP (4, 5) (6). Multiple groups, including our co-investigator Dr. Changhai Ding, reported that MRI signal intensity alteration in IFP is strongly associated with OA knee structural abnormalities and may serve as an imaging biomarker to predict OA progression in patients (7-10). However, we have limited knowledge regarding the regulation of synovium and IFP functions for joint homeostasis and OA development.

2024-03-07 | GSE231755 | GEO

Expression data from MCF7 tumor xenografts treated with either single agent BMS754807, or Tamoxifen or Letrozole alone; or Tamoxifen or Letrozole in combination with BMS754807 for 28 days

Project description:breast cancer. Combined IGF and estrogen-targeted therapy may improve the benefit of hormonal therapy alone. We employed a postmenopausal model of estrogen-dependent breast cancer in vitro and in vivo using the aromatase-expressing MCF-7/AC-1cells. Using this model, we investigated the anti-tumor effects of the dual IGF-1R/InsR tyrosine kinase inhibitor, BMS-754807 alone and in combination with letrozole or tamoxifen in vivo. We used microarrays to compare gene expression changes of MCF7 breast xenograft treated with either BMS754807, or Tamoxifen or Letrozole alone; or Tamoxifen or Letrozole in combination with BMS754807 for 28 days

2011-11-02 | GSE33366 | GEO

Expression data from MCF7 tumor xenografts treated with either single agent BMS754807, or Tamoxifen or Letrozole alone; or Tamoxifen or Letrozole in combination with BMS754807 for 28 days

2011-11-02 | E-GEOD-33366 | biostudies-arrayexpress

Transcription profiling of human estrogen receptor positive MCF7 cells stably transfected with aromatase gene treated with testosterone, 17 B-estradiol, two aromatase inhibitors (letrozole and anastrozole), and an anti-estrogen (tamoxifen)

Project description:Anti-estrogens and aromatase inhibitors are important drugs in the treatment of estrogen-dependent breast cancer. In order to investigate the effects of these drugs on gene expression in breast cancer cells, we treated estrogen receptor-positive MCF-7 cells, stably transfected with the aromatase gene (known as MCF-7aro cells), with testosterone, 17Î²-estradiol, two aromatase inhibitors (letrozole and anastrozole), and an anti-estrogen (tamoxifen). Microarray analyses using Affymetrix Human Genome U133A GeneChips were carried out using total RNA isolated from the control and treated cells. When comparing the effect of each inhibitor on gene expression we observe that letrozole and anastrozole are more similar in terms of the genes they affect, compared to treatment with tamoxifen. The results of this study provide us with a better understanding of the actions of both aromatase inhibitors and anti-estrogens at the molecular level. We believe that the results of this study serve as the first step in identifying unique expression patterns following drug treatment, and that this will ultimately be useful in customizing patient treatment strategies for estrogen-dependent breast cancer. The data presented here have been processed using the R-Project Bioconductor statistical tools package using the affy library. The following were applied: RMA background correction, pmonly probe-level correction, quantile normalization, avgdiff summary method. Raw data is provided in the form of .CEL files.

2007-10-27 | E-GEOD-2225 | biostudies-arrayexpress

Letrozole-, Anastrozole- and Tamoxifen-Responsive Genes in MCF-7aro Cells

Project description:Anti-estrogens and aromatase inhibitors are important drugs in the treatment of estrogen-dependent breast cancer. In order to investigate the effects of these drugs on gene expression in breast cancer cells, we treated estrogen receptor-positive MCF-7 cells, stably transfected with the aromatase gene (known as MCF-7aro cells), with testosterone, 17β-estradiol, two aromatase inhibitors (letrozole and anastrozole), and an anti-estrogen (tamoxifen). Microarray analyses using Affymetrix Human Genome U133A GeneChips were carried out using total RNA isolated from the control and treated cells. When comparing the effect of each inhibitor on gene expression we observe that letrozole and anastrozole are more similar in terms of the genes they affect, compared to treatment with tamoxifen. The results of this study provide us with a better understanding of the actions of both aromatase inhibitors and anti-estrogens at the molecular level. We believe that the results of this study serve as the first step in identifying unique expression patterns following drug treatment, and that this will ultimately be useful in customizing patient treatment strategies for estrogen-dependent breast cancer. The data presented here have been processed using the R-Project Bioconductor statistical tools package using the affy library. The following were applied: RMA background correction, pmonly probe-level correction, quantile normalization, avgdiff summary method. Raw data is provided in the form of .CEL files. Keywords = estrogen-dependent breast cancer Keywords = aromatase Keywords: other

2006-02-02 | GSE2225 | GEO

Wfs1-deficient mouse muscle LC–MSMS

Project description:This dataset reports the analysis of Wfs1-deficient mouse heart, musculus soleus, and white part of musculus rectus femoris by liquid chromatography/tandem mass spectrometry.

2018-11-04 | PXD011019 | Pride

Enrichment of HLA-DR+ neutrophils in osteoarthritic infrapatellar fat pad

Project description:Neutrophils are increasingly recognized as functionally versatile immune cells, with tissue-specific phenotypes that extend beyond their classical role in acute inflammation. In osteoarthritis (OA), neutrophils are abundant in synovial fluid (SF) which has been linked to worse symptoms., yet their presence and function within the infrapatellar fat pad (IFP) remain poorly defined. Here, we characterized neutrophils in OA IFP using flow cytometry, immunofluorescence, proteomics, and functional assays. Weand identified a distinct population of HLA-DR⁺ neutrophils enriched in OA IFP. compared to matched SF. These cells co-expressed classical neutrophil markers and antigen presentation markers. Sorted IFP HLA-DR+ neutrophils induced proliferation of autologous CD3⁺ T cells, supporting a role in antigen presentation. Proteomic profiling of OA IFP revealed upregulation of metabolic and enzymatic activities as well as downregulation of apoptotic and enzyme inhibition pathways, consistent with the increased fibrosis and neovascularization observed histologically. Our findings suggest that IFP-resident neutrophils adopt a tissue adapted, antigen-presenting phenotype, with potential roles in T cell activation, fibrosis, and angiogenesis. Collectively, our findings expand the functional scope of neutrophils in arthritic diseases, further establishing their potential in antigen presentation, and positions the IFP as a previously underappreciated, immunologically active niche in OA pathogenesis.

2026-03-23 | PXD073289 | Pride

ER ChIP-seq of Androstenedione treated Letrozole Resistant Breast Cancer Cell line

Project description:Acquired resistance to aromatase inhibitor (AI) therapy is a major clinical problem in the treatment of breast cancer. The detailed mechanisms of how tumour cells develop this resistance remain unclear. Here estrogen receptor ChIPseq analysis identifies adaptations of the ER in response to prolonged letrozole treatment.

2016-03-21 | GSE54592 | GEO

Aging attenuates the infrapatellar fat pad’s paracrine capacity to promote extracellular matrix production in aged chondrocytes

Project description:Objective: To elucidate the age and sex-specific impact of the IFP secretome on aged chondrocytes, and uncover the exact mechanism driving these effects. To explore mediators of the IFP on chondrocytes, we performed mass-spectrometry proteomics of CM from young versus aged male IFP and mass spectrometry on aged male chondrocytes treated with CM of the same experimental groups. Network analysis interrogated age-dependent changes in communication between IFP-derived secreted proteins and chondrocytes. Results: Col2 and aggrecan expression were significantly increased in chondrocytes co-cultured with young IFP tissue compared to aged IFP tissue, and young CM compared to aged CM. There was no significant increase in SOX9 under any of the different conditions. Similar trends were seen in female experiments. Multi-omics results combined with network analysis suggested IFPs secrete succinate co-A ligase related factors that regulate Hox-dependent spliceosome gene expression in chondrocytes in an age-dependent manner. Conclusions: This study suggests that a young IFP secretome enhances ECM production by aged chondrocytes, in part through enhanced mitochondrial activity. However, this beneficial effect decreases with age.

2024-12-31 | GSE264710 | GEO

Expression data from MCF-7aro aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro lines.

Project description:MCF-7aro cells were used to generate a cell culture model system that is resistant to 3 aromatase inhibitors (AIs), letrozole, anastrozole and exemestane. For comparison, the MCF-7aro cells were also used to generate the tamoxifen-resistant cells as well as long-term estrogen deprived, LTEDaro. Affymetrix microarray analysis was performed to determine changes in gene expression that are unique to AI-resistance. Keywords: cell lines, aromatase inhibitor resistance, tamoxifen resistance

2008-03-22 | GSE10911 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data